04.05.2021 • NewsK+S

K+S Closes Americas Salt Sale to Stone Canyon

German potash and salt producer K+S has completed the sale of its Americas salt business to US-based global industrial holding company Stone Canyon Industries Holdings. Burkhard Lohr, chairman of the board of executive directors at K+S, said the transaction is a major step toward reducing the company’s debt.

The Americas business comprises K+S Chile, acquired in 2006 and formerly known as SPL, Morton Salt (USA), acquired in 2009, as well as Windsor Salt (Canada). Taking into account debt and cash, the purchase price was roughly €2.6 billion.

Stone Canyon will integrate the newly acquired assets into Kissner Group Holdings, which it bought in 2020. Headquartered in Overland Park, Kansas, Kissner produces bulk, specialty and evaporated salt for customers across the US and Canada. Going forward, the K+S Americas business will be known as Morton Salt.

The sale’s closure on Apr. 30 followed antitrust clearance by the US Department of Justice on Apr. 19. However, in order to get the deal approved, Stone Canyon has to divest its US Salt subsidiary in Watkins Glen, New York.

Author: Elaine Burridge, Freelance Journalist

German potash and salt producer K+S has completed the sale of its Americas salt...
German potash and salt producer K+S has completed the sale of its Americas salt business to US-based global industrial holding company Stone Canyon Industries Holdings. The sale’s closure on Apr. 30 followed antitrust clearance by the US Department of Justice on Apr. 19. (c) K+S

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.